R&D Clinical Trials Round-Up: March and April 2026 March and April offered no shortage of talking points for the clinical trials community.
R&D Medical education: Bridging science and clinical practice Emily Harrison, founder and managing director of Nexus Healthcare Education, explains the critical role medical education plays.
R&D Sponsored The UK life sciences sector at a crossroads: Bold decisions ... We all want the same thing: for the UK to succeed, for our workforces to thrive, and for patients and the NHS to benefit.
R&D Sponsored Beyond weight loss: How obesity trial design is evolving For many years, body weight sat at the centre of obesity drug development.
R&D The changing multiple sclerosis landscape: Earlier diagnosis... Multiple sclerosis (MS) is undergoing a meaningful evolution in how it is understood, diagnosed, and managed.
R&D Navigating the strategic path to enantiopurity A closer look at how controlled crystallisation and complementary approaches can be used to efficiently separate and purify chiral molecules.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
